University of Illinois at Chicago: Breast Neoplasms trials

The registry lists 14 Breast Neoplasms studies with University of Illinois at Chicago as lead sponsor. 8 are open to participants now and 1 have results posted.

Phase 1 4Phase 2 5Phase 3 1Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects, Metabolic Mechanisms and Predictors of Response to Acupuncture in Treating Psychoneurological Symptoms Among Breast Cancer SurvivorsNot yet recruitingNCT07695948Phase 3
• BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire DisorderNot yet recruitingNCT07596212Phase 1/2
• Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.RecruitingNCT07387445Not applicable
• BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast CancerRecruitingNCT06441890Phase 2
• Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)RecruitingNCT06169371Phase 4
• BRE-08 Phase II Study of CMC Regimen for Early Stage Breast CancerRecruitingNCT06085742Phase 2
• Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer CareRecruitingNCT05483283Not applicable
• BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast CancerRecruitingNCT04891068Phase 2
• Empowering Latinas to Obtain Breast Cancer ScreeningsCompletedNCT02964234Not applicableResults posted
• WeCanManage. An mHealth Self-management ToolCompletedNCT06185738Not applicable
• Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer SurvivorsCompletedNCT05615753Phase 1
• Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer SurvivorsCompletedNCT05417451Phase 2
• Phase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsCompletedNCT01639911Phase 1
• Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerStatus unknownNCT00002616Phase 1